Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations Source: Eur Respir J, 53 (4) 1900147; 10.1183/13993003.00147-2019 Year: 2019
The rationality of the use of NIV in elderly patients with acute COPD exacerbation Source: International Congress 2018 – Non-invasive ventilation for acute respiratory failure Year: 2018
Compliance of COPD patients to their treatment Source: Eur Respir J 2003; 22: Suppl. 45, 244s Year: 2003
The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation Source: Annual Congress 2013 –COPD treatment and others Year: 2013
Are current treatment recommendations suited to elderly patients with asthma or COPD? Source: Eur Respir Mon; 2009: 43: 267–285 Year: 2009
Regional differences in the treatment of patients with moderate COPD enrolled in a global clinical trial Source: Annual Congress 2006 - Recent advances in the treatment of COPD Year: 2006
Opioid prescription for severe chronic breathlessness to hospitalised patients with COPD - a clinical audit Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020
Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Source: International Congress 2015 – New data on established treatments for COPD Year: 2015
Could a domiciliary COPD care management programme be cost-effective in severe COPD patients? Source: Annual Congress 2005 - Chronic care in respiratory failure Year: 2005
Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers Year: 2006
Treatment eligibility of mepolizumab-treated severe asthma patients in clinical practice Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019
Comparison of the effectiveness of two schedules of pulmonary rehabilitation in patients with severe COPD Source: Eur Respir J 2006; 28: Suppl. 50, 555s Year: 2006
Exacerbation types by COPD severity; risk of hospitalisation by patients not seeking treatment Source: Eur Respir J 2003; 22: Suppl. 45, 353s Year: 2003
Exploration and development of practice with non invasive ventilation (NIV) to patients with chronic obstructive pulmonary disease (COPD) in exacerbation based on the patients, their relatives and healthcare professionals perspectives on treatment Source: Annual Congress 2012 - Nursing led education and follow-up strategies: impact on readmission, self care and patient experiences Year: 2012
Severe outcomes of COVID-19 among patients with COPD and asthma Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020 Year: 2021
Enough is enough: misuse of NIV in the treatment of chronic patients with exacerbation of symptoms? Source: Annual Congress 2013 –The dark side of the moon: when, why, and where I should not use NIV? Year: 2013
Predictors of survival in severe COPD patients initiated on chronic NIV Source: International Congress 2016 – New horizons for noninvasive ventilation in acute and chronic settings Year: 2016
Diagnosis and treatment of COPD patients who respond to steroids Source: International Congress 2017 – State of the art session: "Airway diseases" Year: 2017
Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? Source: Eur Respir J, 54 (4) 1901597; 10.1183/13993003.01597-2019 Year: 2019
Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? Source: Eur Respir J, 54 (4) 1901405; 10.1183/13993003.01405-2019 Year: 2019